A Triple Ring and MediBeacon Collaboration
January 27, 2017
Join Triple Ring’s Kim Shultz, PhD, at SPIE Photonics West on January 30th as she presents work from our collaboration with MediBeacon, a company developing the first real-time non-invasive kidney function monitor.
Our friends at MediBeacon will discuss the development and clinical trial results from their pilot prototype as well as a preclinical device. Kim will follow with a discussion of the modeling work Triple Ring has done with MediBeacon to interpret the results from their pilot study and form the basis of design modifications for the next version of the prototype.
MediBeacon papers being presented include:
Transcutaneous measurement of glomerular filtration rate in conscious laboratory animals: state of the art and future perspectives
Time: 4:20 PM – 4:40 PM
Author(s): Jochen Friedemann, Daniel Schock-Kusch, Yury Shulhevich, MediBeacon GmbH (Germany)
Development and clinical trial results of a prototype device for trans-cutaneous monitoring of kidney function
Time: 4:40 PM – 5:00 PM
Author(s): Martin P. Debreczeny, Richard B. Dorshow, MediBeacon, LLC (United States)
Modeling of transdermal fluorescence measurements from first-in-human clinical trials for renal function determination using fluorescent tracer agent MB-102
Time: 5:00 PM – 5:20 PM
Author(s): Kimberly M. Shultz, Triple Ring Technologies, Inc. (United States); Martin P. Debreczeny, Richard B. Dorshow, MediBeacon, LLC (United States); Jennifer E. Keating, Kate L. Bechtel, Triple Ring Technologies, Inc. (United States)
Click here to learn more about Triple Ring’s participation at SPIE Phontonics West 2017.